Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Share buyback programme – week 28
-
PropertyStream and Offr Launch TRANSACT as UK Homebuying Enters the Digital Era
-
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
-
NAMIB, the New Electronic Warfare Payload Successfully Completes a Collaborative Flight with a Rafale
-
LEADING EDGE MATERIALS ANNOUNCES C$ 6,000,000 NON-BROKERED PRIVATE PLACEMENT WITH BINDING STANDBY SUBSCRIPTION AND COMMITMENT OF CORNERSTONE SHAREHOLDER
-
FLSmidth: Transactions under share buy-back programme
-
Quadient UK Open Locker Network Surpasses 3,000 Locations Nationwide
-
Rock Tech Lithium Awarded $262,500 from Ontario's Critical Minerals Innovation Fund to Advance Made-in-Ontario Lithium Supply Chain
-
BALG Report: Bicycle Hit-and-Run Accidents Reach Record High Across US
-
Share repurchase programme: Transactions of week 28 2026
-
LTM Partners with Anthropic to Accelerate Claude Adoption and Expand Enterprise Delivery
-
Stellantis Reports Q2 2026 Estimated Consolidated Shipments of 1.6 Million Units, +10% Year-Over-Year
-
Orosur Mining Inc Announces Holding(s) in Company
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 13
-
Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary
-
Sofinnova Partners Appoints David Evans as Partner
-
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
-
Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
-
NX Group Launches "Global Charter Desk" to Meet Urgent Transport Needs
-
This September, SIAL Guangzhou Unveils 7 Trends Shaping China's F&B Industry
-
Ontex announces details for its Q2 and H1 2026 results publication
-
Gardaq A/S exploration JV funding secured
-
Share Buy-back Programme – Transactions Week 28
-
NBPE Announces Transaction in Own Shares
-
Tryg shares are traded ex-dividend
-
Orosur Mining Inc Announces Block Listing Six Monthly Return
-
BeritaWire Adapts to a News Cycle That No Longer Waits for Traditional PR
-
Elbit Systems to Report Second Quarter 2026 Financial Results on August 11, 2026
-
Former INTERPOL President H.E. Ahmed Naser Al-Raisi Joins Robo.ai as Chairman of Neurovia AI to Build Trusted, Sovereign AI Infrastructure in the UAE and GCC Region
-
Sampo plc’s share buybacks week 28/2026
-
Sivers Board Completes Purchase of Shares as Approved at the June 2026 AGM
-
Why Bitcoin Search Trends Make Crypto PR More Important for Web3 Brands
-
Next Crypto To Explode: AlphaPepe Brings AI Pre-Swap Analysis to the Crypto DEX Trading
-
Best Crypto To Buy Now: Binance Sees Institutions Return as AlphaPepe Builds the Exchange PEPE Never Had
-
Cardano Price Prediction: ADA Bulls Eye $1.50 Breakout While AlphaPepe Sells Token-Safety to Traders
-
5 Best Crypto Presales With 100x Potential as AlphaPepe’s AI DEX Angle Meets the Stablecoin Plumbing Boom
-
SCENESSE® approved for EPP in Canada
-
Geneva retains top spot in Arcadis' 2026 global construction cost rankings as clients seek greater control over delivery certainty
-
Climate and Net Zero Energy Debate Challenge issued by Friends of Science Society to UN Group by Same Name
-
Start of Day Message
-
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
-
Banqup Group secures continued support from its senior lenders through additional funding
-
Aktsiaselts Infortar own share acquisition transactions
-
T-RANKS Celebrates 15 Years of Delivering Premium Backlink Services Through Evolving Search Algorithms
-
JML Trades Launches New Brand Bringing Plumbing, Gas, Air Conditioning and Roofing Services Together
-
Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET
-
Ruins highlight efforts to trace, preserve roots
-
New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
-
ALZHEIMER'S ASSOCIATION LAUNCHES "PROTECT-COG" STUDY TO TEST U.S. POINTER LIFESTYLE AND GLP-1 OR SIMILAR DRUG TO CUT RISK OF COGNITIVE DECLINE
-
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA
